Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes — Serdar Farhan (2017) | RDL Network
Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes
JACC. Cardiovascular imaging 12(4): 733-741
Article 2017 English
Authors
SF
Serdar Farhan
BR
Björn Redfors
AM
Akiko Maehara
Abstract
2 min read
Objectives
The aim of this study was to investigate the impact of pre-diabetes (pre-DM) on coronary plaque characteristics and ischemic outcomes in patients with acute coronary syndromes (ACS).
Background
Pre-DM (i.e., the early stages of glucometabolic disturbance) is common among patients with ACS, but the extent to which pre-DM influences coronary plaque characteristics and the risk for adverse ischemic events is unclear.
Methods
In the PROSPECT (Providing Regional Observations to Study Predictors of Events in Coronary Tree) study, patients with ACS underwent quantitative coronary angiography, grayscale intravascular ultrasound, and radiofrequency intravascular ultrasound after successful percutaneous coronary intervention. Patients were divided into 3 groups according to their glucometabolic status, as defined by the American Diabetes Association: normal glucose metabolism (NGM), pre-DM, and diabetes mellitus (DM). These groups were compared with regard to coronary plaque characteristics and the risk for major adverse cardiac events (MACEs) (defined as cardiac death or arrest, myocardial infarction, or rehospitalization for unstable or progressive angina).
Results
Among 547 patients, 162 (29.6%) had NGM, 202 (36.9%) had pre-DM, and 183 (33.4%) had DM. There were no significant differences between the groups with regard to intravascular ultrasound findings indicative of vulnerable plaques. Patients with DM had a higher crude rate of MACEs than those with pre-DM or NGM (25.9% vs. 16.3% and 16.1%; p = 0.03 and p = 0.02, respectively). In an adjusted Cox regression model using NGM as the reference group, DM (hazard ratio: 2.20; 95% confidence interval: 1.25 to 3.86; p = 0.006) but not pre-DM (hazard ratio: 1.29; 95% confidence interval: 0.71 to 2.33; p = 0.41) was associated with increased risk for MACEs.
Conclusions
Impaired glucose metabolism is common among patients presenting with ACS. DM but not pre-DM is associated with an increased risk for MACEs. Thus, preventing patients from progressing from pre-DM to DM is important. (PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions; NCT00180466)
Serdar Farhan, Björn Redfors, Akiko Maehara, Thomas McAndrew, Ori Ben‐Yehuda, Bernard De Bruyne, Roxana Mehran, Birgit Vogel, Gennaro Giustino, Patrick W. Serruys, Gary S. Mintz, Gregg W. Stone
Steven P. Marso, Nestor Mercado, Akiko Maehara, Giora Weisz, Gary S. Mintz, John McPherson, François Schiele, Dariusz Dudek, Martin Fahy, Ke Xu, Alexandra J. Lansky, Barry Templin, Zhen Zhang, Bernard De Bruyne, Patrick W. Serruys, Gregg W. Stone
Usman Baber, Gregg W. Stone, Giora Weisz, Pedro R. Moreno, George Dangas, Akiko Maehara, Gary S. Mintz, Ecaterina Cristea, Martin Fahy, Ke Xu, Alexandra J. Lansky, Bertil Wennerblom, Detlef G. Mathey, Barry Templin, Zhen Zhang, Patrick W. Serruys, Roxana Mehran
Yong Xie, Gary S. Mintz, Junqing Yang, Hiroshi Doi, Andrés Íñiguez, George Dangas, Patrick W. Serruys, John McPherson, Bertil Wennerblom, Ke Xu, Giora Weisz, Gregg W. Stone, Akiko Maehara
Discussion(0)
No comments yet. Be the first to comment.